Michael Rizzari
Overview
Explore the profile of Michael Rizzari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
181
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Markmann J, Abouljoud M, Ghobrial R, Bhati C, Pelletier S, Lu A, et al.
JAMA Surg
. 2022 Jan;
157(3):189-198.
PMID: 34985503
Importance: Ischemic cold storage (ICS) of livers for transplant is associated with serious posttransplant complications and underuse of liver allografts. Objective: To determine whether portable normothermic machine perfusion preservation of...
12.
Ivanics T, Leonard-Murali S, Mouzaihem H, Moonka D, Kitajima T, Yeddula S, et al.
Transpl Int
. 2021 Sep;
34(12):2856-2868.
PMID: 34580929
The impact of hyponatremia on waitlist and post-transplant outcomes following the implementation of MELD-Na-based liver allocation remains unclear. We investigated waitlist and postliver transplant (LT) outcomes in patients with hyponatremia...
13.
Al-Kurd A, Kitajima T, Delvecchio K, Shamaa M, Ivanics T, Yeddula S, et al.
Transpl Int
. 2021 Jun;
34(8):1422-1432.
PMID: 34170584
While adverse effects of prolonged recipient warm ischemia time (rWIT) in liver transplantation (LT) have been well investigated, few studies have focused on possible positive prognostic effects of short rWIT....
14.
Nagai S, Suzuki Y, Kitajima T, Ivanics T, Shimada S, Kuno Y, et al.
Liver Transpl
. 2021 May;
27(11):1563-1576.
PMID: 34043869
The Organ Procurement and Transplantation Network (OPTN)/United Network for Organ Sharing (UNOS) policy regarding kidney allocation for liver transplantation (LT) patients was implemented in August 2017. This study evaluated the...
15.
Kitajima T, Moonka D, Yeddula S, Collins K, Rizzari M, Yoshida A, et al.
Liver Transpl
. 2021 Mar;
27(8):1217-1218.
PMID: 33786986
No abstract available.
16.
Kitajima T, Moonka D, Yeddula S, Collins K, Rizzari M, Yoshida A, et al.
Liver Transpl
. 2021 Jan;
27(7):971-983.
PMID: 33492764
Although recent studies have reported favorable outcomes in living donor liver transplantation (LDLT), it remains unclear which populations benefit most from LDLT. This study aims to evaluate LDLT outcomes compared...
17.
Kitajima T, Henry M, Ivanics T, Yeddula S, Collins K, Rizzari M, et al.
Transplantation
. 2021 Jan;
105(12):2571-2578.
PMID: 33449608
Background: Graft-versus-host disease (GVHD) after liver transplantation (LT) is a rare but serious complication. The aim of this study is to identify risk factors, including immunosuppressive regimens, for mortality due...
18.
Yankol Y, Bugeaud E, Zens T, Rizzari M, Mecit N, Leverson G, et al.
Turk J Med Sci
. 2020 Oct;
51(2):610-622.
PMID: 33037873
Background/aim: The progression of chronic kidney disease (CKD) in recipients of living-donor liver transplant (LDLT) compared to deceased-donor liver transplant (DDLT) has not been studied in the literature. We hypothesize...
19.
Ivanics T, Rizzari M, Moonka D, Al-Kurd A, Delvecchio K, Kitajima T, et al.
Am J Transplant
. 2020 Aug;
21(3):1100-1112.
PMID: 32794649
The success of direct-acting antiviral (DAA) therapy has led to near-universal cure for patients chronically infected with hepatitis C virus (HCV) and improved post-liver transplant (LT) outcomes. We investigated the...
20.
Nagai S, Chau L, Kitajima T, Yeddula S, Collins K, Rizzari M, et al.
Am J Transplant
. 2020 Mar;
20(8):2184-2197.
PMID: 32155314
With the introduction of Model for End-Stage Liver Disease-Sodium (MELD-Na)-based allocation, the score at which patients benefit from liver transplantation (LT) has shifted from a score of 15 to 21....